The Value and Significance of Life Span and Scheduled Termination Data in Long-term Toxicity and Carcinogenesis Studies

Abstract

Consideration is given to the age association of lesions, the duration of long-term toxicity and carcinogenesis studies, and to the value and significance of including scheduled termination in such long-term studies. There is now enough evidence that age and cancer are associated. It is argued that the increase in incidence of lesions with age has such disadvantages that extension of the duration of the long-term toxicity and carcinogenicity study beyond 2 years is not warranted in most cases. Incorporation of scheduled termination in long-term studies gives more insight into the biologic behavior of toxic lesions and cancer and may enable one to make a distinction between “incidental” and “fatal” lesions. This distinction may be important for the statistical evaluation of data from chemical carcinogenesis studies.

References

1. Anisimov VN and Turusov VS (1981). Modifying effect of aging on chemical carcinogenesis. A review. Mech. Ageing Dev. 15: 399–414.

2. Burek JD (1978). Pathology of Aging Rats. CRC Press Inc., West Palm Beach, FL, pp. 1–230.

3. Falk HL (1980). Extrapolating carcinogenesis data from animals to humans. Fed. Proc. 39: 76–80.

4. Fears TR , Tarone EE , and Chu KC (1977). False-positive and false-negative rates for carcinogenicity screens. Cancer Res. 37: 1941–1945.

5. Grice HC and Burek JD (1984). Age-associated (geriatric) pathology: Its impact on long-term toxicity studies. In: Current Issues in Toxicology, HC Grice (ed). Springer-Verlag, New York, pp. 57–107.

6. Haseman JK (1983). A reexamination of false-positive rates for carcinogenesis studies. Fundam. Appl. Toxicol. 3: 334–339.

7. Kroes R (1979). Animal data, interpretation and consequences. In: Environmental Carcinogenesis, P Emmelot and E Kriek (eds). Elsevier/North-Holland Biomedical Press, Amsterdam, pp. 287–302.

8. McConnell EE (1983). Pathology requirements for rodent two-year studies. I. A review of current procedures. Toxicol. Pathol. 11: 60–76.

9. Moloney WC , Boschetti AE , and King VP (1974). Spontaneous leukemia in Fischer rats. Cancer Res. 33: 573–574.

10.

10. Peto R , Pike MC , Day NE , Gray RS , Lee PN , Parish S , Peto J , Richards S , and Wahrendorf J (1980). Guildelines for simple, sensitive significance tests for carcinogenic effecs in long-term animal experiments. IARC Monogr. Eval. Carcinog. Risk Chem. Hum. Supplement 2: 311–426.

11.

11. Solleveld HA , Haseman JK , and McConnell EE (1984). Natural history of body weight gain, survival and neoplasia in the F344 rat. J. Natl. Cancer Inst. 72: 929–940.

12.

12. Stromberg PC and Vogtsberger LM (1983). Pathway of the mononuclear cell leukemia of Fischer rats. I. Morphologic studies. Vet. Pathol. 20: 698–708.

13.

13. Turek FW and Desjardins C (1975). Development of Leydig cell tumors and onset of changes in the reproductive and endocrine systems of aging F344 rats. J. Natl. Cancer Inst. 63: 969–975.

14.

14. Ward JM , Goodman DG , Squire RA , Chu KC , and Linhart MS (1979). Neoplastic and nonneoplastic lesions in aging (C57BL/6NxC3H/HeN)F1 (B6C3F1) mice. J. Natl. Cancer Inst. 63: 849–854.

15.

15. Williams GA and Weisburger JH (1983). New approaches to carcinogen bioassay. In: Safely Evaluation and Regulation of Chemicals, F Homburger (ed). Karger, Basel, pp. 200–209.

16.

16. Zurcher C , van Zwieten MJ , Solleveld HA , and Hollander CF (1982). Aging research. In: The Mouse in Biomedical Research. Experimental Biology and Oncology, HL Foster , JD Small , and JG Fox (eds). Academic Press, New York, Vol. 4, pp. 11–35.

17.

17. Zurcher C , van Zwieten MJ , Solleveld HA , van Bezooijen CFA , and Hollander CF (1982). Possible influence of multiple pathological changes in aging rats on studies of organ aging, with emphasis on the liver. In: Liver and Aging-Liver and Drugs, K. Kitani (ed). Elsevier Biomedical Press, New York, pp. 19–36.